Stay updated on Clinical Trial: Camlipixant PK with Rifampin and Rabeprazole
Sign up to get notified when there's something new on the Clinical Trial: Camlipixant PK with Rifampin and Rabeprazole page.

Latest updates to the Clinical Trial: Camlipixant PK with Rifampin and Rabeprazole page
- CheckyesterdayChange DetectedThe clinical trial record is now displayed, including study design, eligibility, interventions, outcomes, results dates, and study documents for the camlipixant drug-interaction study.SummaryDifference59%

- Check8 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check14 days agoChange DetectedA site-wide banner announces an NIH terminology transition, saying agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check21 days agoChange DetectedThe ClinicalTrials.gov page remains a 403 Forbidden error, with its footer revision indicator changing from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check28 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check49 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the usual study details with an access-restricted screen. This reflects an access or server issue rather than a content update.SummaryDifference20%

Stay in the know with updates to Clinical Trial: Camlipixant PK with Rifampin and Rabeprazole
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Camlipixant PK with Rifampin and Rabeprazole page.